TWO SIGMA ADVISERS, LP - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 100 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 1.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$88,430
-79.1%
47,800
-87.4%
0.00%
-100.0%
Q4 2022$422,355
-36.4%
380,500
+34.1%
0.00%
-50.0%
Q3 2022$664,000
-31.6%
283,800
-11.5%
0.00%
-33.3%
Q2 2022$971,000
-56.2%
320,500
-1.8%
0.00%
-50.0%
Q1 2022$2,217,000
-49.5%
326,500
-37.9%
0.01%
-45.5%
Q4 2021$4,388,000
+56.9%
525,500
+39.6%
0.01%
+57.1%
Q3 2021$2,797,000
+89.0%
376,500
+73.0%
0.01%
+75.0%
Q2 2021$1,480,000
+74.1%
217,600
+162.8%
0.00%
+100.0%
Q1 2021$850,000
+385.7%
82,800
+227.3%
0.00%
+100.0%
Q2 2020$175,000
-25.5%
25,300
-48.8%
0.00%0.0%
Q1 2020$235,000
-77.2%
49,400
-58.2%
0.00%
-50.0%
Q4 2019$1,031,000
+119.8%
118,100
-16.2%
0.00%
+100.0%
Q3 2019$469,000
-37.6%
140,900
-7.2%
0.00%
-50.0%
Q2 2019$752,000
-37.4%
151,900
-21.6%
0.00%
-33.3%
Q1 2019$1,202,000
+33.4%
193,800
-27.5%
0.00%
+50.0%
Q4 2018$901,000
-33.3%
267,400
+28.7%
0.00%
-33.3%
Q3 2018$1,350,000
+124.6%
207,700
+164.6%
0.00%
+50.0%
Q2 2018$601,00078,5000.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders